Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
5.82
-0.04 (-0.68%)
At close: Mar 27, 2026, 4:00 PM EDT
5.91
+0.09 (1.54%)
After-hours: Mar 27, 2026, 7:59 PM EDT
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $48.59 million as of March 27, 2026. Its market cap has increased by 191.94% in one year.
Market Cap
48.59M
Enterprise Value
36.53M
1-Year Change
191.94%
Ranking
Category
Stock Price
$5.82
Market Cap Chart
Since June 10, 2019, Edesa Biotech's market cap has increased from $37.12M to $48.59M, an increase of 30.89%. That is a compound annual growth rate of 4.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 48.59M | 310.56% |
| Dec 31, 2025 | 11.83M | 103.14% |
| Dec 31, 2024 | 5.83M | -59.72% |
| Dec 29, 2023 | 14.46M | -65.40% |
| Dec 30, 2022 | 41.80M | -45.08% |
| Dec 31, 2021 | 76.11M | 70.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entera Bio | 51.82M |
| MiNK Therapeutics | 51.73M |
| Acrivon Therapeutics | 51.53M |
| Actuate Therapeutics | 50.98M |
| RenovoRx | 50.95M |
| Metagenomi Therapeutics | 49.66M |
| OS Therapies | 49.65M |
| Radiopharm Theranostics | 48.82M |